REHOVOT, Israel - CollPlant Biotechnologies (NASDAQ: CLGN), currently valued at $40.7 million in market capitalization, ...

CollPlant (CLGN) announced it has been granted U.S. Patent No. 12,186,449 related to its photocurable dermal filler product candidate. The ...

Men worldwide are getting their "fill" with a new penile enhancement procedure made in Dallas.

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio, today announced ...

Crown Laboratories, a portfolio company of Hildred Capital, has acquired Revance Therapeutics, a Nashville-based provider of dermal fillers. No financial terms were disclosed. Crown is a Johnson City, ...

By Christy Santhosh (Reuters) -Evolus said on Thursday the U.S. drug regulator has approved its two new anti-wrinkle gels, expanding the company's product portfolio beyond its cosmetic injection ...

A Trusted Name in Aesthetic Medical Supplies Medical professionals require reliable sources for high-quality products to ...

A SAGGING neck has long been seen as a tell-tale sign of ageing. But it could be time to ditch those scarves and roll-neck ...

Lip filler is becoming more and more popular, but going to a respected and trustworthy healthcare provider is key.

Evolus said the Food and Drug Administration approved its injectable hyaluronic acid gels, known as Evolysse Form and Evolysse Smooth, in line with management expectations.

Evolus (EOLS) announced that the Food and Drug Administration has approved Evolysse Form and Evolysse Smooth injectable hyaluronic acid gels, ...